Konstantina Fylaktakidou

Prof. Konstantina Fylaktakidou


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
KFKonstantina Fylaktakidou
Konstantina Fylaktakidou
DHD. Hadjipavlou-Litina
D. Hadjipavlou-Litina
KLK. Litinas
K. Litinas
EVE. Varella
E. Varella
DND. Nicolaides
D. Nicolaides
Amidoximes are compounds bearing both a hydroxyimino and an amino group at the same carbon atom which makes them versatile building blocks for the synthesis of various heterocycles. Their importance in chemistry along with their rich biology, make amidoximes an attractive target for medicinal chemists, biochemists and biologists. Amidoximes and simple O-substituted derivatives possess very important biological activities functioning as antituberculotic, antibacterial, bacteriostatic, insecticidal, elminthicidal, antiviral, herbicidal, fungicidal, antineoplastic, antiarrythmic, antihypertensive, antihistaminic, anxiolytic-antidepressant, anti-inflammatory/ antioxidant, antiaggregatory (NO donors) or plant growth regulatory agents. A number of amidoximes has already been used as drugs, or currently being in clinical trials. Their numerous pharmaceutical applications have been recently enriched, due to the fact that some mechanistic pathways, concerning their conversion to amidines, as well as their ability to release NO were clarified, giving a new insight to their mode of action and allowing the design of new therapeutic agents. The main subject of the present review paper is to highlight aspects concerning chemical and biological questions on this interesting class of compounds. Some new synthetic methodologies as well as improvements of previously reported general reactions involving amidoximes, acylated amidoximes, and amidines are presented. The biological applications of amidoximes over the end of 2006 are also extensively reviewed.

1 October 2020 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
CKChrisoula Kakoulidou
Chrisoula Kakoulidou
PGPanagiotis S. Gritzapis
Panagiotis S. Gritzapis
AHAntonios G. Hatzidimitriou
Antonios G. Hatzidimitriou
KFKonstantina Fylaktakidou
Konstantina Fylaktakidou
GPGeorge Psomas
George Psomas

1 June 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IDIsmini Doulou
Ismini Doulou
CKChristos Kontogiorgis
Christos Kontogiorgis
AKAlexandros E. Koumbis
Alexandros E. Koumbis
EEEleni Evgenidou
Eleni Evgenidou
DHDimitra Hadjipavlou-Litina
Dimitra Hadjipavlou-Litina
KFKonstantina Fylaktakidou
Konstantina Fylaktakidou

22 January 2016 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
APA. Papastergiou
A. Papastergiou
SPS. Perontsis
S. Perontsis
PGP. Gritzapis
P. Gritzapis
AKAlexandros E. Koumbis
Alexandros E. Koumbis
MKM. Koffa
M. Koffa
KFKonstantina Fylaktakidou
Konstantina Fylaktakidou
Several stable O-alkyl and aryl sulfonyl conjugated p-nitro-Ph and o-, m-, p-pyridine N′-hydroxy imidamides, were subjected to UV irradiation at 312 nm with supercoiled circular plasmid DNA pBluescript KS II. The generated amidinyl and sulfonyloxyl radicals led to effective DNA photo-cleavage. Both alkyl and aryl sulfonyl derivatives were active and the order p-pyridine > p-nitro-Ph > o-pyridine > m-pyridine was schematized for the N′-hydroxy imidamides moiety. Calf thymus-DNA affinity studies which comprised UV interactions, viscosity experiments and competitive studies with ethidium bromide showed good to excellent affinity of the compounds. These properties revealed sulfonyl amidoximes as novel effective DNA-photo-cleavers and may serve in the discovery of new leads for “on demand” biotechnological and medical applications.

1 May 2016 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Open access
NANicolaos-Panagiotis Andreou
Nicolaos-Panagiotis Andreou
KDKonstantinos Dafnopoulos
Konstantinos Dafnopoulos
CTChristos Tortopidis
Christos Tortopidis
AKAlexandros E. Koumbis
Alexandros E. Koumbis
MKMaria Koffa
Maria Koffa
KFKonstantina Fylaktakidou
Konstantina Fylaktakidou
Sulfonyloxyl radicals, readily generated upon UV irradiation of p-pyridine sulfonyl ethanone oxime derivatives, effectively cleave DNA, in a pH independent manner, and under either aerobic or anaerobic conditions. p-Pyridine sulfonyl ethanone oxime derivatives were synthesized from the reaction of p-pyridine ethanone oxime with the corresponding sulfonyl chlorides in good to excellent yields. All compounds, at a concentration of 100μM, were irradiated at 312nm for 15min, after incubation with supercoiled circular pBluescript KS II DNA and resulted in extended single- and double- strand cleavages. The cleavage ability was found to be concentration dependent, with some derivatives exhibiting activity even at nanomolar levels. Besides that, p-pyridine sulfonyl ethanone oxime derivatives showed good affinity to DNA, as it was observed with UV interaction and viscosity experiments with CT DNA and competitive studies with ethidium bromide. The compounds interact to CT DNA probably by non-classical intercalation (i.e. groove-binding) and at a second step they may intercalate within the DNA base pairs. The fluorescence emission spectra of pre-treated EB-DNA exhibited a significant or moderate quenching. Comparing with the known aryl carbonyloxyl radicals the sulfonyloxyl ones are more powerful, with both aryl and alkyl sulfonyl substituted derivatives to exhibit DNA photo-cleaving ability, in significantly lower concentrations. These properties may serve in the discovery of new leads for "on demand" biotechnological and medical applications.

18 October 2022 in Dalton Transactions
Verified
Journal Article
Open access
PDF file
CKChrisoula Kakoulidou
Chrisoula Kakoulidou
CCChristos Chasapis
Christos Chasapis
AHAntonios G. Hatzidimitriou
Antonios G. Hatzidimitriou
KFKonstantina Fylaktakidou
Konstantina Fylaktakidou
GPGeorge Psomas
George Psomas
Two novel halogenated (Br- and F-) quinazoline derivatives, namely [(E)-4-(2-((6-bromopyridin-2-yl)methylene)hydrazinyl)quinazoline] (L1) and [(E)-4-(2-((3-fluoropyridin-2-yl)methylene)hydrazinyl) quinazoline] (L2), were synthesized and characterized. Their interaction with a series of metal(II) ions (= Mn(II), Ni(II), Cu(II), Zn(II) and Cd(II)) resulted in the formation of six mononuclear complexes characterized by spectroscopic techniques and single-crystal X-ray crystallography. The complexes bear the formulae [Ni(L1)2](NO3)2 (1), [Zn(L2)2](NO3)(PF6) (2), [Cd(L2)(H2O)(CH3OH)(NO3)](NO3) (3), [Cu(L2)Cl2] (4), [Ni(L2)2](NO3)2 (5) and [Mn(L2)(CH3OH)(Cl)2] (6). The biological activity of the compounds was further evaluated in vitro regarding their interaction with calf-thymus DNA, their cleavage ability towards supercoiled circular pBR322 plasmid DNA in the absence or presence of irradiation at various wavelengths (UVA, UVB and visible light), their affinity to bovine serum albumin and their ability to scavenge 1,1-diphenyl-picrylhydrazyl and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radicals and to reduce H2O2. In silico molecular docking calculations were employed to study the behavior of the complexes towards calf-thymus DNA and bovine serum albumin.